118 results

• Diabetes Smartphone Alerts May Be Impacted by Hardware, Software Updates: FDA Warns

  February 7, 2025

  Martha Garcia

  The FDA is warning that smartphone updates may accidentally disable apps being used to monitor diabetes patients, resulting in severe injuries or death.

• Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks

  October 7, 2024

  Irvin Jackson

  FDA has announced a class I recall impacting tens of thousands of Medtronic MiniMed insulin pumps, due to risks that the battery may deplete rapidly after the device has been dropped or physically impacted.

• Study Finds Jardiance Does Not Significantly Reduce Heart Failure or Mortality Rates Among Patients

  May 13, 2024

  Grace Muller

  A new study finds the heart benefits of Jardiance are minimal at best, despite years of advertising by the manufacturers claiming superior cardiovascular benefits for diabetes patients.

• Case Study Links Tepezza Side Effects to a Potential Risks for Diabetics

  October 4, 2023

  Irvin Jackson

  Tepezza side effects may cause a loss of glycemic control and increased risk of diabetic ketoacidosis, according to the findings of a new study.

• Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study

  October 8, 2021

  Irvin Jackson

  The findings of a new study indicate taking cholesterol drugs like Lipitor and Zocor could speed up the progression of diabetes, increasing the risk of adverse health complications.

• Diabetic Ketoacidosis Risk Tripled Among Users of Invokana, Similar Diabetes Drugs: Study

  August 5, 2020

  Irvin Jackson

  A new study appears to confirm FDA warnings that Invokana and similar diabetes drugs increase the risk of diabetic ketoacidosis in type 2 diabetes patients.

• Invokana, Farxiga and Similar Drugs Need Stronger Ketoacidosis Warnings for Type 1 Diabetics: Public Citizen

  July 7, 2020

  Irvin Jackson

  Public Citizen has petitioned the FDA to add black box warnings to Invokana and similar drugs, contraindicating their use by Type 1 diabetics due to the risk of diabetic ketoacidosis.

• Flesh-Eating Fournier Gangrene Infections Linked to Invokana, Farxiga, Other SGLT2 Drugs: FDA Study

  May 14, 2019

  Irvin Jackson

  A new study by FDA researchers appears to verify links between Invokana and similar diabetes drugs and a life-threatening infection that attacks the genitals.

• Invokana Lawsuit Filed Over Right Leg Amputation

  January 3, 2019

  Irvin Jackson

  A new Invokana lawsuit indicates that the side effects of the diabetes drug caused a Louisiana woman to have her right leg amputated above the knee.

• Jardiance, Farxiga Also Carry Lower Limb Amputation Risk, Not Just Invokana: Study

  November 21, 2018

  Irvin Jackson

  A new study warns that the diabetes drugs Farxiga and Jardiance may share Invokana's increased risk of foot amputation.